How to Move Forward After a Thumbs Down from FDA: Interview with Kevin Sidow, Former CEO and President of Moximed

In late 2016, I was able to sit down with Kevin Sidow. At the
time he was President & Chief Executive Officer for Moximed,
and had been since 2008.

Prior to his time at Moximed, Kevin was President & CEO for
St. Francis Medical Technologies, a privately held,
venture-funded company focused on developing innovative
treatments for patients suffering from degenerative spinal
disorders. In January 2007, St. Francis Medical Technologies was
sold for $725 million to Kyphon, which was acquired by Medtronic
later that same year.


Previously, Kevin was the Worldwide President of DePuy, where he
supervised the global orthopedic, spine, trauma, and sports
medicine businesses, with annual revenue responsibility of over
$3 billion dollars. Kevin holds a B.S. in Accounting from West
Virginia University.

Here are a few of the things we learned from Kevin:

- How Kevin felt when Moximed’s first patient was treated with
the Atlas System after 8+ years of research and
development.

- What makes the Atlas System different than other orthopedic
knee implants.

- How medtech professionals looking to take the next step in
their career can utilize Kevin’s advice and learn from his
meteoric rise to Worldwide President of DePuy.


See more...